A New study conducted by nova-Institute and ordered by CropEnergies, which will be presented and discussed for the first time in Brussels on 26 September 2017, conducts quantitative and qualitative sustainability assessment of biofuels against the background of the EU’s REDII negotiations. This comprehensive sustainability assessment carried out by the German company led by Michael Caurs “shows that first generation bioethanol is as advantageous as second generation bioethanol for a feasible climate strategy”. According the nova-Institute “the results clearly indicate that the systematic discrimination against first generation biofuels of the current Commission proposal is in no way founded on scientific evidence. It would be counterproductive to further lower the share of first generation fuels in the EU’s energy mix”.
Rome will be the Euro-mediterranean capital of the bioeconomy for a couple of days. The Italian Forum on Industrial Biotechnology and Bioeconomy (IFIB) goes to the Italian capital from 5 to 6 October at the Palazzo Rospigliosi, in front of the House of the President of the Republic.
The second edition of the Bioeconomy Investment Summit will take place on 14-15 December in Helsinki, Finland, organized by the European Commission and the European Forest Institute. Over 30 speakers from across the globe will share their views on how we can bring together the economy and the environment. “New advances in technology – the organizers say – mean that everything that can be made out of oil can be made from renewable, biological resources. There are huge environmental and business opportunities for a wide range of industries: construction, chemicals, textiles, energy, plastics”.
“Clusters can set an environment for investment and implementation. They can bring the right people together and help to identify both hurdles and how to overcome them, for example by scouting technologies or helping to find access to funding”. To say it – in this long and exclusive interview with Il Bioeconomista – is Tatjana Schwabe, scientific advisor at CLIB2021, the German cluster of industrial biotechnology based in Düsseldorf. With Schwabe with talk about the role of clusters in supporting the European bioeconomy.
Interview by Mario Bonaccorso
Genomatica has strong results for its GENO BDO biobased process technology regarding overall process performance and production volume to date for bio-based 1,4-butanediol (BDO). Novamont, Genomatica’s first GENO BDO licensee, has officially confirmed that its new industrial plant in Bottrighe, Italy has met all performance guarantees committed to by Genomatica. The guarantees include technical and economic parameters, such as efficiency of converting feedstock sugars to Bio- BDO product and product quality. The process runs as designed, as modeled, and as represented.
There is a new partnership in the world bioeconomy. Indian Oil Corporation Limited, India’s flagship national oil company and, LanzaTech, carbon recycling company based in Illinois, signed a Statement of Intent to construct the world’s first refinery off gas-to-bioethanol production facility in India.
Italian oil giant Eni, the City of Turin, GTT (Gruppo Torinese Trasporti) and Amiat, an Iren Group company, have signed an agreement to launch a large-scale experimental project with Turin buses using Eni Diesel+, the new Eni fuel with a 15% of renewable component. Under the agreement, the Turin public transport company will pay Eni Diesel+ at the same price as the diesel fuel that its vehicles have used on the urban network up to now. This follows Eni’s success at the tender to supply the fuel for Turin’s buses.
“The UK cannot solve the problem on its own, and we will need to collaborate with foreign governments and companies if we are to truly tackle the crisis ahead.” To say it referring to Brexit – in this exclusive interview with Il Bioeconomista – is Jaymin Amin, COO at Ingenza, the spin-out from the University of Edinburgh founded in 2002, which is today one of the most dynamic European industrial biotech company. With Amin we talk about industrial biotechnology and bioeconomy in Scotland.
Interview by Mario Bonaccorso
Amyris, the U.S. industrial bioscience company, and the Government of Queensland, Australia, announced the next step their plans to develop a leading industrial biotechnology hub in Southeast Asia. Plans call for developing a new production plant with support from local partners to produce Amyris’s sugar cane-based ingredient called farnesene, which is used in products including cosmetic emollients, fragrances, nutraceuticals, polymers, and lubricants.